The Future Of NSF: Four Key Issues Require Clarification

A recent article in The Scientist, headlined "NSF Still Wrestling With Science Board Over Recommendations For Agency Future" (Barton Reppert, Feb. 8, 1993, page 1), discussed the report of the National Science Board's Commission on the Future of the National Science Foundation. This commission, of which I was a member, was asked to answer two questions: (a) How can NSF best ensure its continued support of basic academic research? and (b) What, if anything, should NSF do differently to meet the

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The commission answered these questions, but, as The Scientist correctly noted, the report was worded rather ambiguously. Bruce Smith, a science policy analyst at the Brookings Institution, was quoted as saying about the report: "It's like the Dead Sea Scrolls, written in some kind of strange code." I rather agreed with Smith, and felt strongly that the issues surrounding NSF's future are so important that the commission's views should have been expressed with much greater clarity.

For this reason, shortly after the report was given to the National Science Board, I wrote to the board to describe the four key points in the report on which I thought the commission was in full agreement, but which did not come through with the clarity they deserved. Here are the four points:

1. The National Science Board must not remain passive while enormous changes are taking place in the United States science ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies